Fresenius Kabi is a global health care company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition, and we supply the US oncology market with one of the largest injectable oncology portfolios in the industry. We’re now committed to launching a range of biosimilars in the U.S. with our BioSpecialized approach to health care. From the collaborative way we work with health care professionals to how we manufacture and deliver our products, we are committed to going beyond medicines to support patient care.